Human Milk Oligosaccharides

Nestlé Research: Supporting infant microbiome development without compromising gut ecology

29-Feb-2024 By Olivia Haslam

The ‘ecology of strains’ is imperative to consider in the research of the infant microbiome, as not all Bifidobacterium strains work equally, Dr. Bernard Berger, R&D expert microbiome and probiotics at Nestlé Research told NutraIngredients.

Chr. Hansen receives landmark approvals for HMOs in global markets

16-Sep-2022 By Nicola Gordon-Seymour

Chr. Hansen has received regulatory approval to supply a range of Human Milk Oligosaccharides (HMO) to new and existing global markets, following recent endorsements from Australia and New Zealand last year.

HMO levels in human milk linked to infant cognitive development: Abbott Study

25-Feb-2021 By Stephen Daniells

Levels of two specific human milk oligosaccharides (HMOs) are linked with measure of infant cognitive development, says a pilot study led by R&D Abbott Nutrition.

Gut simulation expands health benefits of HMOs in adults

28-Sep-2020 By Stephen Daniells

The potential health effects of human milk oligosaccharides (HMOs) for adults may extend beyond just promoting the growth of beneficial Bifidobacteria to also impacting immune function and the gut barrier, says a new study.

HMOs for NEC: Abbott-Johns Hopkins researchers unlock breastmilk prebiotics intestinal mechanism

09-Apr-2020 By Stephen Daniells

Human milk oligosaccharides (HMOs) may prevent the development of necrotizing enterocolitis (NEC) in premature infants by inhibiting a specific receptor in the intestine linked to inflammation, researchers from Johns Hopkins and Abbott report for the...